LON:BELL Belluscura (BELL) Share Price, News & Analysis GBX 0.75 0.00 (0.00%) As of 07/24/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsBuy This Stock About Belluscura Stock (LON:BELL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Belluscura alerts:Sign Up Key Stats Today's Range 0.75▼ 0.7550-Day Range 0.72▼ 1.0752-Week Range 0.50▼ 18VolumeN/AAverage Volume3.84 million shsMarket Capitalization£1.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations. Read More Receive BELL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Belluscura and its competitors with MarketBeat's FREE daily newsletter. Email Address BELL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com BELL Stock Analysis - Frequently Asked Questions How have BELL shares performed this year? Belluscura's stock was trading at GBX 8.81 on January 1st, 2025. Since then, BELL stock has decreased by 91.5% and is now trading at GBX 0.75. How do I buy shares of Belluscura? Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:BELL CIKN/A Webwww.belluscura.com PhoneN/AFaxN/AEmployees24Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (9.37) Trailing P/E RatioN/A Forward P/E Ratio0.99 P/E GrowthN/ANet Income-£29.55 million Net Margins-1,030.73% Pretax MarginN/A Return on Equity-102.62% Return on Assets-43.53% Debt Debt-to-Equity RatioN/A Current Ratio3.25 Quick Ratio5.13 Sales & Book Value Annual Sales£2.87 million Price / Sales0.66 Cash FlowGBX 0.09 per share Price / Cash Flow8.00 Book ValueGBX 11.70 per share Price / Book0.06Miscellaneous Outstanding Shares252,048,266Free FloatN/AMarket Cap£1.89 million OptionableNot Optionable Beta1.05 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:BELL) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belluscura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
